CVS Health Corp (NYSE:CVS)
$ 55.82 0.14 (0.25%) Market Cap: 70.07 Bil Enterprise Value: 138.78 Bil PE Ratio: 9.81 PB Ratio: 0.94 GF Score: 81/100

Q4 2018 CVS Health Corp Earnings Call Transcript

Feb 20, 2019 / 01:30PM GMT
Release Date Price: $64.22 (-8.10%)
Michael P. McGuire
CVS Health Corporation - SVP of IR

Good morning, everyone, and thank you for standing by. Welcome to the conference call to discuss CVS Health's fourth quarter 2018 results and 2019 outlook. As a reminder, this call is being recorded on Wednesday, February 20, 2019.

I'm Mike McGuire, Senior Vice President of Investor Relations for CVS Health. I'm joined this morning by Larry Merlo, President and CEO; and Eva Boratto, Executive Vice President and CFO. Following our prepared remarks, we'll host a question-and-answer session. (Operator Instructions)

In addition to this call and our press release, we have posted a slide presentation on our website that summarizes the information in our prepared remarks as well as some additional facts and figures regarding our operating performance and guidance. Our 10-K will be filed later this month, and that, too, will be available on our website once filed.

I have one announcement this morning. Our annual Investor Day has been scheduled for Tuesday, June 4, in New York City. You will have the opportunity to hear from our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot